News
PETS
4.110
-2.61%
-0.110
PetMed Express Non-GAAP EPS of -$0.10, revenue of $65.3M beats by $0.3M
Seeking Alpha · 3d ago
PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024
PetMed Express just reported results for the third quarter of 2024. The company reported earnings per share of -10 cents. PetMed Express reported revenue of $65.32 million. This was 0.49% better than the analyst estimate for revenue of -20 million.
Investorplace · 3d ago
PetMed Express, Inc. Quarterly Report for the Period Ended December 31, 2023
Press release · 3d ago
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
TipRanks · 3d ago
PetMed Express Q3 2024 EPS $(0.10) Misses $(0.01) Estimate, Sales $65.317M Beat $65.000M Estimate
PetMed Express reports quarterly losses of $0.10 per share. The company reported quarterly sales of $65.317 million which beat the analyst consensus estimate by 10.95%. The company missed the analyst estimate by 900 percent. PetMed Express also reported quarterly loss of $1.07 per share in the same period last year.
Benzinga · 3d ago
PetMed Express Q3 2024 GAAP EPS $(0.10), Sales $65.317M Beat $65.000M Estimate
Benzinga · 3d ago
*PetMed Express 3Q Loss $2.0M >PETS
Dow Jones · 3d ago
*PetMed Express 3Q Loss/Shr $0.10 >PETS
Dow Jones · 3d ago
PETMED EXPRESS INC: QTRLY SHR LOSS $0.10
Reuters · 3d ago
PETMEDS® ANNOUNCES FISCAL 2024 THIRD QUARTER FINANCIAL RESULTS AND COMPLETION OF FINANCIAL RESTATEMENT
Reuters · 3d ago
Press Release: PetMeds(R) Announces Fiscal 2024 -3-
Adjusted EBITDA does not reflect transaction related costs and other items which are not representative of PetMed Express' underlying operations. The company's results should only be considered a supplement to other GAAP financial performance measures. The company reports its results on a non-GAAP basis.
Dow Jones · 3d ago
*PetMed Express 3Q Sales $65.3M >PETS
Dow Jones · 3d ago
Press Release: PetMeds(R) Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
PetMeds Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results. AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% last year. Strong balance sheet with $49.4 million of cash The Company is now current in all of its SEC filings.
Dow Jones · 3d ago
PETMED EXPRESS - ADDITIONAL ERRORS IDENTIFIED RELATING TO VALUATION OF DEFERRED TAXES ASSOCIATED WITH CO'S PETCARERX ACQUISITION IN APRIL 2023
Reuters · 3d ago
PETMED EXPRESS INC SAYS RESTATING PREVIOUSLY ISSUED AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR YEARS ENDED MARCH 31, 2023, 2022, AND 2021
Reuters · 3d ago
Weekly Report: what happened at PETS last week (0408-0412)?
Weekly Report · 3d ago
PetMed: Fiscal Q3 Earnings Snapshot
PetMed Express reported a loss of $2 million in its fiscal third quarter. The pet pharmacy company posted revenue of $65.3 million in the period. The Delray Beach, Florida-based company said it had a lost of 10 cents per share in the quarter.
Barchart · 3d ago
The Implied Analyst 12-Month Target For VCR
NASDAQ · 04/10 14:54
Weekly Report: what happened at PETS last week (0401-0405)?
Weekly Report · 04/08 09:18
Weekly Report: what happened at PETS last week (0325-0329)?
Weekly Report · 04/01 09:18
More
Webull provides a variety of real-time PETS stock news. You can receive the latest news about Petmed Express Inc through multiple platforms. This information may help you make smarter investment decisions.
About PETS
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.